After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing layoffs for about 30 workers. After reporting more than two dozen deaths of trial ...

In the wake of a recent safety scare in a confirmatory trial of its antibody-drug conjugate Zynlonta, ADC Therapeutics is tightening its belt in an effort to get the most out of its cancer med. On ...

Pfizer’s high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. The pharma giant announced Monday that sigvotatug vedotin, the first new ADC to read out pivotal data following its ...

Abstract: Wireline receiver front-ends increasingly utilize high-speed time-interleaved ADCs for improved equalization through subsequent digital processing and ...

Abstract: ADC designs are progressing rapidly over time in terms of architectural developments and circuit innovations. In this talk, we will focus on high-precision designs and on low-power design ...